Congress bans 18 toxic chemicals from food packaging—here's who pays

What it does

This bill bans 18 specific toxic chemicals and chemical classes (including PFAS, phthalates, BPA, asbestos, benzene, and formaldehyde) from food packaging and food-contact materials. It requires the FDA to treat these substances as unsafe, gives manufacturers 2 years to reformulate, and explicitly allows states to impose stricter rules. The bill protects infants, children, pregnant women, workers, and communities with disproportionate exposure.

Why we flagged it

The bill's core function is a straightforward regulatory ban on named toxic chemicals in food packaging, with explicit public-health rationale (vulnerable populations) and a reasonable phase-in period. This is direct consumer-protection legislation, not a hidden carve-out or rider.

What the text implies

• Manufacturers of food packaging and food-contact materials will face significant reformulation costs and supply-chain disruption, likely raising consumer prices for packaged food in the short term.
• The 2-year phase-in may create a compliance cliff: companies that delay reformulation until near the deadline could face simultaneous supply shortages and regulatory enforcement.
• PFAS bans in food packaging may accelerate broader PFAS litigation and regulatory action in other sectors (textiles, firefighting foam, water treatment), creating cascading liability exposure.
• The bill's explicit deference to state law may trigger a patchwork of state-level bans stricter than the federal floor, fragmenting national food-packaging standards and increasing compliance complexity for multi-state manufacturers.

Who it affects

Ordinary people—especially children, pregnant women, and workers—face reduced exposure to known or suspected carcinogens and endocrine disruptors in everyday food packaging. The 2-year phase-in allows industry time to adapt without sudden disruption, and the bill preserves state authority to go further, maximizing public health protection.

Who stands to gain

• alternative packaging material manufacturers
• chemical companies producing non-toxic substitutes
• environmental and public-health advocacy organizations
• litigation firms specializing in consumer/toxic-tort claims

Named in the bill

FDA, PFAS (perfluoroalkyl/polyfluoroalkyl substances), BPA (Bisphenol A), phthalates, Westmoreland Resource Recovery (WPM), Ball Corporation (BALL), Packaging Corporation of America (PKG), Hecla Mining Company (PAAS), Amcor plc (AMCR), Federal Food, Drug, and Cosmetic Act Section 409

Where it stands

5 cosponsors: 5 Democrats.

• Jun 9, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Jun 9, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

6 lobbying clients named this bill on 6 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $1,004,000 in lobbying spend. A filing names 14 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 82% of bills with at least one filing.

Richard Blumenthal, the sponsor, reported $111,550 in PAC receipts in the 2026 cycle.

• Food Marketplace Inc — $584,000 on 1 filing
• Plastics Industry Association, Inc. — $150,000 on 1 filing
• Ppg Industries, Inc — $140,000 on 1 filing
• Ppg Industries — $80,000 on 1 filing
• Flexible Packaging Association — $30,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.